Opinions on Potential Merger of Strive Inc. Stock (ASST) with Semler Scientific

Inc. seems to be at the center of attention due to recent talks regarding a potential merger with Semler Scientific. This news has garnered significant interest on social media platforms, igniting a wave of optimism among users who see this move as having a potentially transformative impact, particularly with the potential inclusion of a substantial corporate treasury in Bitcoin. The general sentiment seems to be that a merger could be a game-changer for Strive Inc., with hopes running high for growth prospects in the upcoming year.

When it comes to price predictions for ASST, opinions are divided, creating a mix of projections within the online community. Some forecast a price surge to hover between $2.74 and $4.45 in the short term, while others express even more bullish sentiments. They point to the considerable call option activity surrounding ASST as a positive indicator of confidence in its upward trajectory for the next year. These discussions mirror a delicate balance of caution and excitement, as investors navigate the uncertainties and opportunities presented by the potential merger.

The insider trading activity within Strive Inc. sheds some light on the sentiments of those closely associated with the company. Key figures within the organization, such as VIVEK RAMASWAMY and Chief Executive Officer MATTHEW RYAN COLE, have engaged in stock transactions over the past six months. Notably, these transactions have leaned heavily towards purchases rather than sales, signaling a sense of optimism or confidence from insiders about the company’s future prospects.

In terms of revenue, Strive Inc. reported revenues of $255K in Q3 2025, marking a significant decrease of -74.09% compared to the same period the previous year. Despite this decline, the company’s financial performance continues to attract the attention of hedge funds and institutional investors. Recent data indicates that numerous institutional investors have either increased their positions in Strive Inc. or decreased them in the most recent quarter, showcasing the dynamic nature of investor sentiment towards the company.

Looking at analyst ratings, Wall Street analysts have issued reports on ASST in recent months, with a notable “Buy” rating from Maxim Group on 12/10/2025. This further underscores the positive outlook and potential growth prospects associated with Strive Inc. in the eyes of industry experts and analysts.

Overall, the evolving landscape surrounding Strive Inc. and its potential merger with Semler Scientific presents a myriad of opportunities, challenges, and uncertainties. With the interplay of market sentiments, insider actions, financial performance, and analyst ratings, investors are navigating a complex web of information to make informed decisions about their involvement with ASST stock.